3'-Cyano-2-piperidinomethyl benzophenone, 97.0%, 1g

6-Fluoro-5-iodopyridin-2-amine, 95.0%, 1g

5-Bromo-3-chloro-2-propan-2-yloxypyridine, 97%, 2g

Electroporation cuvettes 100 µl 50 pcs

2-(carboxymethyl)-5-nitrobenzoic acid, 95.0%, 1g

ROTI®Garose-Glu/GST Cartridges, 25 ml, 5 x 5 ml

N-Cbz-1,3-Diaminopropane hydrochloride, 95.0%, 1g

1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 99.00%, 100g

4-(3-((4-Chloro-6-methoxyquinolin-7-yl)oxy)propyl)morpholine, 97%, 250mg

(1H-Pyrrolo[3,2-c]pyridin-2-yl)methanamine dihydrochloride, 95.0%, 5g

ethyl 8-(3,4-dimethylphenyl)-8-oxooctanoate, 97.0%, 2g

1-(2-Chloro-ethyl)-4-isopropyl-piperazinedihydrochloride, 98.0%, 1g

2-Methylbutylamine, 85.0%, 5ml